- Investing Ideas
- Global Pharmaceuticals & Biotech Healthy potentially undervalued
Global Pharmaceuticals & Biotech Healthy potentially undervalued
Results
172
Companies which are potentially undervalued and in an acceptable financial position.
172 companies
Imeik Technology DevelopmentLtd
Market Cap: CN¥28.1b
Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.
300896
CN¥93.35
7D
-4.2%
1Y
-52.8%
High Tide
Market Cap: CA$300.5m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.54
7D
6.3%
1Y
-26.6%
Trulieve Cannabis
Market Cap: US$2.1b
Operates as a cannabis retailer in the United States.
TRLV
US$11.32
7D
16.8%
1Y
27.2%
United Therapeutics
Market Cap: US$22.0b
Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$518.53
7D
0.05%
1Y
67.7%
CorMedix
Market Cap: US$645.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.56
7D
4.8%
1Y
-38.8%
Hypera
Market Cap: R$15.3b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.80
7D
4.9%
1Y
-9.0%
Yunnan Baiyao GroupLtd
Market Cap: CN¥89.2b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥50.00
7D
1.0%
1Y
-13.5%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩248,500.00
7D
0.2%
1Y
-21.6%
Supernus Pharmaceuticals
Market Cap: US$2.6b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$45.36
7D
-7.5%
1Y
2.3%
Green Thumb Industries
Market Cap: CA$2.3b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.55
7D
4.5%
1Y
-14.6%
Vetoquinol
Market Cap: €820.5m
A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
VETO
€70.60
7D
-0.4%
1Y
-2.8%
Elanco Animal Health
Market Cap: US$12.2b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.09
7D
6.1%
1Y
40.2%
UCB
Market Cap: €42.7b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€224.10
7D
3.1%
1Y
12.2%
Dong-E-E-Jiao
Market Cap: CN¥31.2b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥48.89
7D
-5.0%
1Y
-5.9%
Virbac
Market Cap: €2.8b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
VIRP
€329.00
7D
-0.3%
1Y
-1.3%
Diaceutics
Market Cap: UK£121.8m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.44
7D
1.1%
1Y
4.4%
Bavarian Nordic
Market Cap: DKK 16.5b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 218.20
7D
15.4%
1Y
-8.7%
Prestige Consumer Healthcare
Market Cap: US$2.5b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$51.45
7D
1.7%
1Y
-22.5%
ANI Pharmaceuticals
Market Cap: US$1.6b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$75.65
7D
-1.6%
1Y
-17.7%
China Resources Jiangzhong PharmaceuticalLtd
Market Cap: CN¥14.6b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥23.15
7D
-2.3%
1Y
3.3%
Amoy Diagnostics
Market Cap: CN¥6.9b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.99
7D
-4.4%
1Y
-27.3%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.27
7D
0.8%
1Y
-3.8%
Tarsus Pharmaceuticals
Market Cap: US$3.2b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$71.45
7D
0.6%
1Y
21.4%
Cresco Labs
Market Cap: CA$493.2m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.06
7D
2.9%
1Y
-45.6%
Journey Medical
Market Cap: US$223.3m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.53
7D
13.1%
1Y
1.5%
Fennec Pharmaceuticals
Market Cap: US$399.8m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$11.71
7D
-1.3%
1Y
34.9%
Decibel Cannabis
Market Cap: CA$72.1m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.13
7D
8.7%
1Y
-3.8%
China Resources Pharmaceutical Group
Market Cap: HK$29.2b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.65
7D
-5.5%
1Y
-9.5%
Dermapharm Holding
Market Cap: €2.1b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€42.00
7D
4.9%
1Y
22.6%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€60.50
7D
4.3%
1Y
5.8%
Clinuvel Pharmaceuticals
Market Cap: AU$534.5m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.60
7D
2.3%
1Y
-22.6%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥7.9b
Engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products.
300119
CN¥17.48
7D
-7.2%
1Y
-23.6%
Tasly Pharmaceutical Group
Market Cap: CN¥22.0b
Engages in the research, development, production, and sale of pharmaceuticals in China.
600535
CN¥14.75
7D
-4.2%
1Y
-14.3%
ACADIA Pharmaceuticals
Market Cap: US$5.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$30.57
7D
1.3%
1Y
18.9%
Exelixis
Market Cap: US$13.5b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$56.72
7D
6.8%
1Y
47.9%
Zevra Therapeutics
Market Cap: US$691.8m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$12.04
7D
4.1%
1Y
27.9%